Aptose Biosciences Inc.

Aptose Biosciences Inc.verified

APTO

Price:

$1.71

Market Cap:

$4.36M

Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs within the field of oncology, primarily focusing on the United States market. Its active clinical pipeline features several promising candidates. APTO-253 is currently undergoing Phase 1a/b clinical evaluation for patients battling relapsed or treatment-resistant blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS). Another compound, HM43239, is progressing through Phase 1/2 clinical trials, specifically targeting individuals with relapsed or refract...[Read more]

Industry

Biotechnology

IPO Date

1992-03-16

Stock Exchange

NASDAQ

Ticker

APTO

The Enterprise Value as of June 2026 (TTM) for Aptose Biosciences Inc. (APTO) is 3.42M

According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.42M. This represents a change of -16.47% compared to the average of 4.10M of the last 4 quarters.

Aptose Biosciences Inc. (APTO) Historical Enterprise Value (quarterly & annually)

How has APTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Aptose Biosciences Inc. over the last ten years is 1.49B. The current 3.42M Enterprise Value has changed -77.07% with respect to the historical average. Over the past ten years (40 quarters), APTO's Enterprise Value was at its highest in in the March 2021 quarter at 7.90B. The Enterprise Value was at its lowest in in the March 2026 quarter at 3.42M.

Quarterly (TTM)
Annual

Average

1.49B

Median

753.07M

Minimum

3.44M

Maximum

5.73B

Aptose Biosciences Inc. (APTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aptose Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 344.87%

Maximum Annual Enterprise Value = 5.73B

Minimum Annual Increase = -93.19%

Minimum Annual Enterprise Value = 3.44M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20253.44M-90.02%
202434.51M-93.19%
2023506.49M-33.97%
2022767.06M-56.53%
20211.76B-69.22%
20205.73B36.93%
20194.19B344.87%
2018941.35M27.37%
2017739.09M186.74%
2016257.75M-41.89%

Aptose Biosciences Inc. (APTO) Average Enterprise Value

How has APTO Enterprise Value performed in the past?

The current Enterprise Value of Aptose Biosciences Inc. (APTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

181.48M

5-year avg

615.25M

10-year avg

1.49B

Aptose Biosciences Inc. (APTO) Enterprise Value vs. Peers

How is APTO’s Enterprise Value compared to its peers?

Aptose Biosciences Inc.’s Enterprise Value is less than Gamida Cell Ltd. (40.73M), greater than Rubius Therapeutics, Inc. (-13765000.00), greater than Idera Pharmaceuticals, Inc. (-11484000.00), greater than Nabriva Therapeutics plc (-7192677.00), less than Atreca, Inc. (36.62M), less than Gritstone bio, Inc. (43.29M), greater than Aravive, Inc. (-44467140.00), less than RVL Pharmaceuticals plc (16.09M), less than Oncorus, Inc. (42.71M), greater than Affimed N.V. (-19176588.00),

CompanyEnterprise ValueMarket cap
40.73M$4.34M
-13765000.00$0
-11484000.00$0
-7192677.00$323.00
36.62M$3.57M
43.29M$3.80M
-44467140.00$2.95M
16.09M$3.14M
42.71M$0
-19176588.00$2.98M

Build a custom stock screener for Aptose Biosciences Inc. (APTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptose Biosciences Inc. (APTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Aptose Biosciences Inc.'s Enterprise Value?

What is the highest Enterprise Value for Aptose Biosciences Inc. (APTO)?

What is the 3-year average Enterprise Value for Aptose Biosciences Inc. (APTO)?

What is the 5-year average Enterprise Value for Aptose Biosciences Inc. (APTO)?

How does the current Enterprise Value for Aptose Biosciences Inc. (APTO) compare to its historical average?